Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study

Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study

(2022) Silvia J. Leon et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease

(2022) Sunil Bhandari et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019)

(2022) Aimin Yang et al.   EBioMedicine

Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4

(2022) Aimin Yang et al.   Pharmaceuticals

Long-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study

(2021) Aimin Yang et al.   DIABETOLOGIA

Data Resource Profile: The Hong Kong Diabetes Surveillance Database (HKDSD)

(2021) Hongjiang Wu et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study

(2020) Hongjiang Wu et al.   DIABETOLOGIA

Overlap Weighting

(2020) Laine E. Thomas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Why Test for Proportional Hazards?

(2020) Mats J. Stensrud et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate

(2020) Yao Qiao et al.   JAMA Internal Medicine

TEMPORARY REMOVAL: Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: Evidence-based advances in monitoring and treatment

(2020) Ian H. de Boer et al.   KIDNEY INTERNATIONAL

Trends in Glucose-Lowering Drug Use, Glycemic Control, and Severe Hypoglycemia in Adults With Diabetes in Hong Kong 2002–2016

(2020) Aimin Yang et al.   DIABETES CARE

Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948–955

(2020) Edouard L. Fu et al.   DIABETES CARE

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

(2020) George L. Bakris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study

(2020) Edouard L. Fu et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline

(2020) Sankar D. Navaneethan et al.   ANNALS OF INTERNAL MEDICINE

Graphical Depiction of Longitudinal Study Designs in Health Care Databases

(2019) Sebastian Schneeweiss et al.   ANNALS OF INTERNAL MEDICINE

From Hong Kong Diabetes Register to JADE Program to RAMP-DM for Data-Driven Actions

(2019) Juliana C.N. Chan et al.   DIABETES CARE

Hyperkalemia: pathophysiology, risk factors and consequences

(2019) Robert W Hunter et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Imputing missing time-dependent covariate values for the discrete time Cox model

(2019) Havi Murad et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

OUP accepted manuscript

(2018)   AMERICAN JOURNAL OF CLINICAL NUTRITION

Revisiting RAAS blockade in CKD with newer potassium-binding drugs

(2018) Panagiotis I. Georgianos et al.   KIDNEY INTERNATIONAL

Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices

(2017) Brian A. Houston et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Methods for time-varying exposure related problems in pharmacoepidemiology: An overview

(2017) Laura Pazzagli et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study

(2017) Morten Schmidt et al.   BMJ Open

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.

(2016) Miguel A. Hernán et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials

(2016) Xinfang Xie et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arena

(2016) Murray Epstein   Kidney International Supplements

Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry

(2015) A. O. Luk et al.   DIABETIC MEDICINE

Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial

(2015) Sunil Bhandari et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Management of hyperkalaemia in chronic kidney disease

(2014) Csaba P. Kovesdy   Nature Reviews Nephrology

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study

(2011) E. Imai et al.   DIABETOLOGIA

The role of the c-statistic in variable selection for propensity score models

(2010) Daniel Westreich et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease

(2009) A. K. Ahmed et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION